Kofla-Dłubacz Anna, Akutko Katarzyna, Krzesiek Elżbieta, Jamer Tatiana, Braksator Joanna, Grębska Paula, Pytrus Tomasz, Stawarski Andrzej
2nd Department of Paediatrics, Gastroenterology and Nutrition, Faculty of Medicine, Wroclaw Medical University, M. Sklodowskiej-Curie Str. 50/52, 50-367 Wroclawl, Poland.
J Clin Med. 2022 Feb 14;11(4):994. doi: 10.3390/jcm11040994.
Selective interference with the functioning of the immune system consisting of the selective blockade of pro-inflammatory factors is a modern, promising, and developing strategy for the treatment of diseases resulting from dysregulation of the immune system, including inflammatory bowel disease. Inhibition of the TNF alpha pathway, group 12/23 cytokines, and lymphocyte migration is used in the treatment of severe or moderate ulcerative colitis and Crohn's disease. Intracellular signal transduction by influencing the phosphorylation of SAT (signal transducer and activator of transcription) proteins remains in clinical trials.
对由促炎因子的选择性阻断构成的免疫系统功能进行选择性干扰，是一种用于治疗由免疫系统失调引起的疾病（包括炎症性肠病）的现代、有前景且不断发展的策略。抑制肿瘤坏死因子α通路、第12/23组细胞因子和淋巴细胞迁移被用于治疗重度或中度溃疡性结肠炎和克罗恩病。通过影响信号转导及转录激活蛋白（SAT）的磷酸化进行细胞内信号转导仍处于临床试验阶段。
